Skip to main content
. Author manuscript; available in PMC: 2018 Aug 4.
Published in final edited form as: Nat Rev Clin Oncol. 2013 Jul 30;10(9):534–544. doi: 10.1038/nrclinonc.2013.132

Figure 4 |.

Figure 4 |

Role of chemotherapy in metastatic small bowel adenocarcinoma. a | Median overall survival is significantly more in patients receiving palliative chemotherapy (13.7 months) as compared to best-supportive care (4.0 months) alone. b | Response rate to palliative chemotherapy show moderate correlation with median overall survival in metastatic small bowel adenocarcinomas. c | Median progression-free survival on palliative chemotherapy correlates strongly with median survival in metastatic small bowel adenocarcinomas.